Andrea Vergani
Andrea Vergani
Boston Children's Hospital - Harvard medical school
Verified email at
Cited by
Cited by
Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes
P Fiorina, M Jurewicz, A Augello, A Vergani, S Dada, S La Rosa, M Selig, ...
The Journal of Immunology 183 (2), 993-1004, 2009
Targeting CD22 reprograms B-cells and reverses autoimmune diabetes
P Fiorina, A Vergani, S Dada, M Jurewicz, M Wong, K Law, E Wu, Z Tian, ...
Diabetes 57 (11), 3013-3024, 2008
ROCK-isoform-specific polarization of macrophages associated with age-related macular degeneration
S Zandi, S Nakao, KH Chun, P Fiorina, D Sun, R Arita, M Zhao, E Kim, ...
Cell reports 10 (7), 1173-1186, 2015
Role of podocyte B7-1 in diabetic nephropathy
P Fiorina, A Vergani, R Bassi, MA Niewczas, MM Altintas, MG Pezzolesi, ...
Journal of the American Society of Nephrology 25 (7), 1415-1429, 2014
Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7
A Vergani, S Tezza, F D’Addio, C Fotino, K Liu, M Niewczas, R Bassi, ...
Circulation 127 (4), 463-475, 2013
Effect of the purinergic inhibitor oxidized ATP in a model of islet allograft rejection
A Vergani, C Fotino, F D’Addio, S Tezza, M Podetta, F Gatti, M Chin, ...
Diabetes 62 (5), 1665-1675, 2013
A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice
A Vergani, F D'Addio, M Jurewicz, A Petrelli, T Watanabe, K Liu, K Law, ...
diabetes 59 (9), 2253-2264, 2010
Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site
MB Nasr, A Vergani, J Avruch, L Liu, E Kefaloyianni, F D’Addio, S Tezza, ...
Acta diabetologica 52 (5), 917-927, 2015
Targeting the CXCR4–CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1
P Fiorina, M Jurewicz, A Vergani, A Petrelli, M Carvello, F D’Addio, ...
The Journal of Immunology 186 (1), 121-131, 2011
Impact of pancreas transplantation on type 1 diabetes-related complications
C Gremizzi, A Vergani, V Paloschi, A Secchi
Current opinion in organ transplantation 15 (1), 119-123, 2010
Interleukin-10+ regulatory B cells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigens
S Kleffel, A Vergani, S Tezza, MB Nasr, MA Niewczas, S Wong, R Bassi, ...
Diabetes 64 (1), 158-171, 2015
Early increase of retinal arterial and venous blood flow velocities at color Doppler imaging in brittle type 1 diabetes after islet transplant alone
M Venturini, P Fiorina, P Maffi, C Losio, A Vergani, A Secchi, ...
Transplantation 81 (9), 1274-1277, 2006
The mobilization and effect of endogenous bone marrow progenitor cells in diabetic wound healing
P Fiorina, G Pietramaggiori, SS Scherer, M Jurewicz, JC Mathews, ...
Cell transplantation 19 (11), 1369-1381, 2010
Circulating IGF-I and IGFBP3 levels control human colonic stem cell function and are disrupted in diabetic enteropathy
F D’Addio, S La Rosa, A Maestroni, P Jung, E Orsenigo, MB Nasr, ...
Cell stem cell 17 (4), 486-498, 2015
Characterization of donor dendritic cells and enhancement of dendritic cell efflux with CC-chemokine ligand 21: a novel strategy to prolong islet allograft survival
P Fiorina, M Jurewicz, K Tanaka, N Behazin, A Augello, A Vergani, ...
Diabetes 56 (4), 912-920, 2007
Islet transplantation stabilizes hemostatic abnormalities and cerebral metabolism in individuals with type 1 diabetes
F D’Addio, P Maffi, P Vezzulli, A Vergani, A Mello, R Bassi, R Nano, ...
Diabetes Care 37 (1), 267-276, 2014
Near normalization of metabolic and functional features of the central nervous system in type 1 diabetic patients with end-stage renal disease after kidney-pancreas transplantation
P Fiorina, P Vezzulli, R Bassi, C Gremizzi, M Falautano, F D’Addio, ...
Diabetes Care 35 (2), 367-374, 2012
The purinergic system in allotransplantation
A Vergani, S Tezza, C Fotino, G Visner, A Pileggi, A Chandraker, ...
American Journal of Transplantation 14 (3), 507-514, 2014
IL-21 is an antitolerogenic cytokine of the late-phase alloimmune response
A Petrelli, M Carvello, A Vergani, KM Lee, S Tezza, M Du, S Kleffel, ...
Diabetes 60 (12), 3223-3234, 2011
Electrophysiological and MRI evaluation of neurological involvement in Behçet's disease.
C Besana, G Comi, A Del Maschio, L Praderio, A Vergani, S Medaglini, ...
Journal of Neurology, Neurosurgery & Psychiatry 52 (6), 749-754, 1989
The system can't perform the operation now. Try again later.
Articles 1–20